High‐resolution crystal structures of the botulinum neurotoxin binding domains from subtypes A5 and A6
Clostridium botulinum neurotoxins (BoNTs) cause flaccid paralysis through inhibition of acetylcholine release from motor neurons; however, at tiny doses, this property is exploited for use as a therapeutic. Each member of the BoNT family of proteins consists of three distinct domains: a binding doma...
Main Authors: | Jonathan R. Davies, Amy Britton, Sai Man Liu, K. Ravi Acharya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.12931 |
Similar Items
-
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
by: Michael W. Peck, et al.
Published: (2017-01-01) -
Crystal structure of botulinum neurotoxin subtype A3 cell binding domain in complex with GD1a co‐receptor ganglioside
by: Kyle S. Gregory, et al.
Published: (2020-03-01) -
Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics
by: Jonathan R. Davies, et al.
Published: (2018-10-01) -
Mechanism of Ganglioside Receptor Recognition by Botulinum Neurotoxin Serotype E
by: Geoffrey Masuyer, et al.
Published: (2021-08-01) -
Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
by: Bernard Poulain, et al.
Published: (2019-01-01)